收费全文 | 3314篇 |
免费 | 203篇 |
国内免费 | 6篇 |
耳鼻咽喉 | 13篇 |
儿科学 | 170篇 |
妇产科学 | 58篇 |
基础医学 | 353篇 |
口腔科学 | 120篇 |
临床医学 | 322篇 |
内科学 | 588篇 |
皮肤病学 | 51篇 |
神经病学 | 343篇 |
特种医学 | 305篇 |
外国民族医学 | 3篇 |
外科学 | 229篇 |
综合类 | 55篇 |
一般理论 | 1篇 |
预防医学 | 260篇 |
眼科学 | 100篇 |
药学 | 188篇 |
中国医学 | 1篇 |
肿瘤学 | 363篇 |
2021年 | 22篇 |
2019年 | 23篇 |
2018年 | 34篇 |
2017年 | 21篇 |
2016年 | 30篇 |
2015年 | 36篇 |
2014年 | 52篇 |
2013年 | 78篇 |
2012年 | 84篇 |
2011年 | 103篇 |
2010年 | 84篇 |
2009年 | 84篇 |
2008年 | 160篇 |
2007年 | 143篇 |
2006年 | 157篇 |
2005年 | 141篇 |
2004年 | 127篇 |
2003年 | 131篇 |
2002年 | 105篇 |
2001年 | 97篇 |
2000年 | 110篇 |
1999年 | 96篇 |
1998年 | 53篇 |
1997年 | 67篇 |
1996年 | 67篇 |
1995年 | 49篇 |
1994年 | 40篇 |
1993年 | 65篇 |
1992年 | 81篇 |
1991年 | 77篇 |
1990年 | 87篇 |
1989年 | 84篇 |
1988年 | 67篇 |
1987年 | 71篇 |
1986年 | 83篇 |
1985年 | 65篇 |
1984年 | 70篇 |
1983年 | 50篇 |
1982年 | 45篇 |
1981年 | 29篇 |
1980年 | 41篇 |
1979年 | 57篇 |
1978年 | 35篇 |
1977年 | 28篇 |
1976年 | 25篇 |
1975年 | 30篇 |
1973年 | 26篇 |
1972年 | 23篇 |
1970年 | 20篇 |
1969年 | 27篇 |
Methodology:
A cross-sectional measurement of clinical characteristics and energy and fat intakes in patients attending the CF outpatients clinic of the John Hunter Hospital, Newcastle was undertaken. Twenty-nine subjects, mean age 12 years (range 4.3–20.2), completed weighed food records to determine the contribution of fat to the percentage of the recommended energy intake obtained and to document use of pancreatic enzyme replacement therapy.
Results:
Diets with a high percentage of energy derived from fat did not guarantee that individuals with CF met their energy requirements. Subjects with total fat intakes of 100 g per day or greater, however, achieved in excess of 110% recommended daily intake (RDI) for energy. Up to 47% of subjects consumed more pancreatic enzyme replacement capsules than shown to give maximum effectiveness.
Conclusion:
Setting a 100 g daily fat target is a realistic way of ensuring high energy intakes in CF. Fat ready reckoners would identify the fat content of food and prescribe specific numbers of pancreatic enzyme replacement capsules to be consumed with each meal or food item. 相似文献
Methods and Materials: The outcome for 75 patients receiving radiation for desmoid tumor with or without complete gross resection between 1965 and 1994 was retrospectively reviewed utilizing univariate and multivariate statistical methods.
Results: With a median follow-up of 7.5 years, the overall freedom from relapse was 78% and 75% at 5 and 10 years, respectively. Of the total, 23 patients received radiation for gross disease because it was not resectable. Of these 23 patients, 7 sustained local recurrence, yielding a 31% actuarial relapse rate at 5 years. Radiation dose was the only significant determinant of disease control in this group. A dose of 50 Gy was associated with a 60% relapse rate, whereas higher doses yielded a 23% relapse rate (p < 0.05). The other 52 patients received radiation in conjunction with gross total resection of tumor. The 5- and 10-year relapse rates were 18% and 23%, respectively. No factor correlated significantly with disease outcome. There was no evidence that radiation doses exceeding 50 Gy improved outcome. Positive resection margins were not significantly deleterious in this group of irradiated patients. For all 75 patients, there was no evidence that radiation margins exceeding 5 cm beyond the tumor or surgical field improved local-regional control. Ultimately, 72 of the 75 patients were rendered disease-free, but 3 required extensive surgery (amputation, hemipelvectomy) to achieve this status. Significant radiation complications were seen in 13 patients. Radiation dose correlated with the incidence of complications. Doses of 56 Gy or less produced a 5% 15-year complication rate, compared to a 30% incidence with higher doses (p < 0.05).
Conclusions: Radiation is an effective modality for desmoid tumors, either alone or as an adjuvant to resection. For patients with negative resection margins, postoperative radiation is not recommended. Patients with positive margins should almost always receive 50 Gy of postoperative radiation. Unresectable tumors should be irradiated to a dose of approximately 56 Gy, with a 75% expectation of local control. 相似文献